![Gregory T. Went](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory T. Went
Directeur Général chez
Dextera Biosciences, Inc.
Profil
Gregory T.
Went was the founder of CuraGen Corp., founded in 1992, where the title held was Director & Executive Vice President in 1999.
Dr. Went was the founder of Adamas Pharmaceuticals LLC, founded in 2000, holding the titles of Chairman, President & Chief Executive Officer.
Went was the founder of Tethys Bioscience, Inc., founded in 2002, with the title of Director from 2002 to 2009.
The current job is Chairman & Chief Executive Officer at Dextera Biosciences, Inc. since 2021, with employment starting in 2020.
Former jobs include Chairman & Chief Executive Officer at Neuromolecular Pharmaceuticals, Inc., Director at ParAllele BioScience, Inc., Director at Angelica Therapeutics, Inc., Managing Director at Halteres Associates LLC, and Advisor at Presidio Partners.
Education includes an undergraduate degree from Carnegie Mellon University in 1985 and a doctorate from the University of California, Berkeley in 1990.
Postes actifs de Gregory T. Went
| Sociétés | Poste | Début |
|---|---|---|
Dextera Biosciences, Inc.
 Dextera Biosciences, Inc. BiotechnologyHealth Technology Manufactures protein-based therapeutics and biologics | Directeur Général | 01/08/2021 |
Anciens postes connus de Gregory T. Went
| Sociétés | Poste | Fin |
|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Directeur Général | 11/09/2019 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Fondateur | 01/01/1999 |
ParAllele BioScience, Inc.
 ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Directeur/Membre du Conseil | - |
Neuromolecular Pharmaceuticals, Inc.
 Neuromolecular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological disorders | Président | - |
Halteres Associates LLC
 Halteres Associates LLC Medical/Nursing ServicesHealth Services Engages in development and commercialization of diagnostics services | Corporate Officer/Principal | - |
Formation de Gregory T. Went
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
ParAllele BioScience, Inc.
ParAllele BioScience, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biochemical processes to analyze variations in the human genome | Commercial Services |
Neuromolecular Pharmaceuticals, Inc.
Neuromolecular Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurological disorders | Health Technology |
Tethys Bioscience, Inc.
 Tethys Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biological markers for the clinical diagnostics marketplace | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Dextera Biosciences, Inc.
Dextera Biosciences, Inc. BiotechnologyHealth Technology Manufactures protein-based therapeutics and biologics | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presidio Partners
 Presidio Partners Investment ManagersFinance Presidio Partners invests in companies located in the US. The firm targets companies operating in the fields of information technology, life sciences, and energy technology. They provide financing for early and late stage capital requirements. | Finance |
Angelica Therapeutics, Inc. | |
Halteres Associates LLC
Halteres Associates LLC Medical/Nursing ServicesHealth Services Engages in development and commercialization of diagnostics services | Health Services |
